MedTrace Logo

Nanoparticles Emitted by Aircraft Engines, Impact on Respiratory Function

NCT03098784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 472

Last updated 2017-04-04

No results posted yet for this study

Summary

The goal of this study is to assess the respiratory health of the Air France company's employees working in the Marseilles and Paris airports (flight line and administrative employees). This study was promoted by the Montpellier CHRU, Regional University Hospital Centre (ANSM identification number 2011-A00646-35). It allowes voluntary employees to be involved. They answer a lifestyle survey and perform a spirometry, an exhaled CO measurement and a sampling of exhaled air condensate (EAC). A metrological study of particles emitted by aircraft engines and found in the airport environment will be conducted and the elementary chemical composition analysis, as well a sieve analysis of particles present in the EAC will be conducted.

Conditions

  • Respiratory Function

Interventions

OTHER

Exposure to aircraft exhaust

The exposed group is made up of Air France personnel mainly working in physical proximity to the runways of the Marseille Marignane or Parisian airports. These people are subject to direct exposure to exhaust from aircraft engines.

OTHER

Non exposure to aircraft exhaust

The non-exposed group is made up of Air France personnel working mainly inside buildings at the Marseille Marignane or Parisian airports. These people are not subject to direct exposure to exhaust from aircraft engines.

Sponsors & Collaborators

  • Aix Marseille Université

    collaborator OTHER

  • LBM- Nanosecurity platform - CEA Grenoble

    collaborator UNKNOWN

  • LR2N - Nanosecurity platform - CEA Grenoble

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • NICOLAS MOLINARI · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-06-30
Completion
2012-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03098784 on ClinicalTrials.gov